Australia - English - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - clotrimazole, quantity: 1 % w/w; hydrocortisone acetate, quantity: 1 % w/w - cream - excipient ingredients: light liquid paraffin; purified water; propylene glycol; ceteareth-20; cetostearyl alcohol - broad spectrum anti-fungal and anti-inflammatory cream for dermatophyte and yeast infections of the skin when inflammation is prominent. this includes conditions such as tinea (athlete's foot, jock itch, ring worm), fungal skin rash, thrush infections of the skin, fungally infected nappy rash and eczema/dermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - clotrimazole, quantity: 1 % w/w; hydrocortisone acetate, quantity: 1 % w/w - cream - excipient ingredients: ceteareth-20; propylene glycol; light liquid paraffin; cetostearyl alcohol; purified water - broad spectrum anti-fungal and anti-inflammatory cream for dermatophyte and yeast infections of the skin when inflammation is prominent. this includes conditions such as tinea (athlete's foot, jock itch, ring worm), thrush infections of the skin, and fungally infected eczema/dermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - clotrimazole, quantity: 1 % w/w; hydrocortisone acetate, quantity: 1 % w/w - cream - excipient ingredients: light liquid paraffin; ceteareth-20; purified water; propylene glycol; cetostearyl alcohol - broad spectrum anti-fungal and anti-inflammatory cream for dermatophyte and yeast infections of the skin when inflammation is prominent. this includes conditions such as tinea (athlete's foot, jock itch, ring worm), fungal skin rash, thrush infections of the skin, fungally infected nappy rash and eczema/dermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - hydrocortisone, quantity: 1 % w/w; clotrimazole, quantity: 1 % w/w - cream - excipient ingredients: cetostearyl alcohol; liquid paraffin; glycerol; chlorocresol; purified water; propylene glycol; cetomacrogol 1000; white soft paraffin - for dermatophyte and yeast infections of the skin when inflammation is prominent. this includes conditions such as fungal infected intertrigo.

United States - English - NLM (National Library of Medicine)

proficient rx lp - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum . effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate cream for the treatment of infections caused by zoophilic dermatophytes (e.g., microsporum canis ) has not been established. several cases of treatment failure of clotrimazole and betamethasone dipropionate cream in the treatment of infections caused by microsporum canis have been reported clotrimazole and betamethasone dipropionate cream is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other corticosteroids or i

United States - English - NLM (National Library of Medicine)

hikma pharmacuticals usa usa inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg - clotrimazole is indicated for the local treatment of oropharyngeal candidiasis. the diagnosis should be confirmed by a koh smear and/or culture prior to treatment. clotrimazole is also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration.) clotrimazole is contraindicated in patients who are hypersensitive to any of its components. no data available.

United States - English - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 ml - clotrimazole and betamethasone dipropionate lotion is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum . effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate lotion for the treatment of infections caused by zoophilic dermatophytes (e.g., microsporum canis ) has not been established. clotrimazole and betamethasone dipropionate lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other corticosteroids or imidazoles, or to any ingredient in these preparations.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream and lotion are indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes and trichophyton rubrum. effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate cream or lotion for the treatment of infections caused by zoophilic dermatophytes (e.g. microsporum canis ) has not been established. several cases of treatment failure of clotrimazole and betamethasone dipropionate cream, usp in the treatment of infections caused by microsporum canis have been reported. clotrimazole and betamethasone dipropionate cream or lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dip

United States - English - NLM (National Library of Medicine)

rebel distributors corp - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream and lotion are indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes and trichophyton rubrum. effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate cream or lotion for the treatment of infections caused by zoophilic dermatophytes (e.g. microsporum canis ) has not been established. several cases of treatment failure of clotrimazole and betamethasone dipropionate cream, usp in the treatment of infections caused by microsporum canis have been reported. clotrimazole and betamethasone dipropionate cream or lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipr

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 ml - clotrimazole and betamethasone dipropionate lotion is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes and trichophyton rubrum. effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate lotion for the treatment of infections caused by zoophilic dermatophytes (e.g., microsporum canis ) has not been established. clotrimazole and betamethasone dipropionate lotion is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other corticosteroids or imidazoles, or to any ingredient in this preparation.